Novavax (NVAX) Change in Inventory (2021 - 2026)
Novavax (NVAX) posted quarterly Change in Inventory of $226000.0 for Q1 2026, up 109.52% year-over-year from $107867.8 in Q1 2025, and up 110.52% quarter-over-quarter from -$2.1 million in Q4 2025.
Novavax (NVAX) Change in Inventory (2021 - 2026) Analysis & Trends
Novavax's Change in Inventory history runs 6 years deep, the most recent figure standing at $226000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 109.52% year-over-year to $226000.0; the TTM figure through Mar 2026 stood at $5.8 million (up 281.76% YoY), while the FY2025 annual figure was $3.2 million, up 125.09% from the prior year.
- Change in Inventory for Q1 2026 stood at $226000.0, up from -$2.1 million in the prior quarter.
- The five-year high for Change in Inventory was $304.2 million in Q2 2022, with the low at -$16.8 million in Q1 2024.
- The 5-year median for Change in Inventory is $3.8 million (2025), against an average of $31.9 million.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory soared 478.62% in 2022, then tumbled 1236.51% in 2025.
- Novavax's Change in Inventory stood at $51.3 million in 2022, then slumped by 115.75% to -$8.1 million in 2023, then jumped by 102.34% to $189000.0 in 2024, then slumped by 1236.51% to -$2.1 million in 2025, then soared by 110.52% to $226000.0 in 2026.
- Business Quant data shows NVAX's Change in Inventory at $226000.0 in Q1 2026, -$2.1 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 318,000.00 |
| Jun 30, 2026 | 318,000.00 |
| Mar 31, 2026 | 226,000.00 |
| Mar 31, 2026 | 226,000.00 |
| Dec 31, 2025 | -2.15 Mn |
| Dec 31, 2025 | -2.15 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Mar 31, 2025 | -2.38 Mn |
| Mar 31, 2025 | -2.38 Mn |
| Dec 31, 2024 | 189,000.00 |
| Dec 31, 2024 | 189,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 2.64 Mn |
| Mar 31, 2024 | -16.82 Mn |
| Mar 31, 2024 | -16.82 Mn |